1Headache Classification Committee of the International Headache Society.Classification and diagnostic criteria for headache disorders,cranial neuralgias and facial pain[J].Cepalalgia,1988,8(Suppl 7):1.
2Headache Classification Committee of the International Headache Society.Classification and diagnostic criteria for headache disorders,cranial neuralgias,and facial pain[J].Second Edition.Cephalalgia,2004,24(Suppl 1):1.
3Diener HC,Katsarava Z.Medication overuse headache[J].Curr Med Res Opin,2001,17:17.
5Silberstein SD,Tepper S,Brandes,et al.Randomized,placebo-controlled trial of rofecoxib in the acute treatment of migraine[J].Neurology,2004,62:1552.
6Misra UK,Jose M,Kalita J.Rofecoxib versus ibuprofen for acute treatment of migraine:a randomised placebo controlled trial[J].Postgrd Med J,2004,80:720.
7Balbisi,Ebrahim A.Efficacy and safety of almotriptan malate for migraine[J].American J Health System Pharmacy,2002,59:2184.
8Diener H,Ryan R,Sun W,et al.The 40mg dose of eletriptan:comparative efficacy and tolerability versus sumatriptan 100 mg[J].Eur J Neurol,2004,11:125.
9Syrett NB,Abu-Shakra S,Yates R.Zolmitriptan nasal spray:advances in migraine treatment[J].Neurology,2003,61:S27.
10Silberstein SD,Elkind AH,Schreiber C,et al.A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine[J].Neurology,2004,63:261.
